Previous Close | 149.53 |
Open | 149.75 |
Bid | 101.00 x 800 |
Ask | 160.00 x 800 |
Day's Range | 144.93 - 149.97 |
52 Week Range | 117.64 - 189.00 |
Volume | |
Avg. Volume | 582,195 |
Market Cap | 9.13B |
Beta (5Y Monthly) | 0.87 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.76 |
Earnings Date | Feb 21, 2022 - Feb 25, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 202.00 |
As of midday May 20, 2022, the benchmark S&P 500 (SNPINDEX: ^GSPC) had declined more than 20% from its all-time closing high in early January, which places the widely followed index in a bear market. There's no denying that bear markets can tug at investors' emotions and create jaw-dropping single-session price movements. The uncertainty of not knowing how low the market could go, or precisely how long a bear market could last, tends to feed on these investor fears.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Jazz Pharmaceuticals stock saw a welcome improvement to its Relative Strength (RS) Rating on Tuesday, rising from 78 to 81. When you're researching the best stocks to buy and watch, keep a close on eye on relative price strength. Is Jazz Pharmaceuticals Stock A Buy?